BA.2.75: Test Detects, Differentiates Emerging Subvariant of Interest
Roche and its subsidiary TIB Molbiol have developed a COVID-19 test that detects and differentiates the latest subvariant of interest.
Read More
Search Results for: point-of-care
Cue Health’s Molecular COVID Test Achieves Lab-Based PCR Test Accuracy, Study Shows
Cue Health announced that an independent clinical study demonstrated that its COVID test is as accurate as a centralized lab-based RT-PCR.
Read More
Chembio Diagnostics Evaluates Monkeypox Rapid POC Test Development
Chembio Diagnostics, a POC diagnostics company focused on infectious diseases, is evaluating the potential to develop a monkeypox test.
Read More
Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read More
Researchers Develop Fast, Equipment-Free Test for COVID
Researchers have created an easy-to-use diagnostic test for COVID infection that is more sensitive than commonly used at-home antigen tests.
Read More